Evidence map›Paper›PMID 26519488›Full record

ArticleJournal of clinical pathology2016

IgG is involved in the migration and invasion of clear cell renal cell carcinoma.

Zhengzuo Sheng, Yang Liu, Caipeng Qin, Zhenhua Liu, Yeqing Yuan, FengZhan Hu, Yiqing Du, Huaqi Yin, Xiaoyan Qiu, Tao Xu

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 35 citations in OpenAlex.

  1. Immunoglobulin G in aging and cancer.Frontiers in immunology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Comparison of Non B-Ig and B-Ig.Advances in experimental medicine and biology · 2024
    Review
  7. Review
  8. Non B Cell-Derived Immunoglobulin, A Brighter Horizon for the Future.Advances in experimental medicine and biology · 2024
    Review
  9. Review
  10. The Expression of Non B Cell-Derived Immunoglobulins.Advances in experimental medicine and biology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zhengzuo ShengDepartment of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Yang LiuDepartment of Immunology, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing, China Peking University Center for Human Disease Genomics, Beijing, China.
Caipeng QinDepartment of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Zhenhua LiuDepartment of Urology, Beijing Jishuitan Hospital, Beijing, China.
Yeqing YuanDepartment of Urology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
FengZhan HuDepartment of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Yiqing DuDepartment of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Huaqi YinDepartment of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Xiaoyan QiuDepartment of Immunology, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing, China Peking University Center for Human Disease Genomics, Beijing, China.
Tao XuDepartment of Urology, Second Clinical Medical College of Peking University, Peking University People's Hospital, Beijing, China.
Peking University · CNPeking University People's Hospital · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate if IgG can be expressed in clear cell renal cell carcinoma (cRCC) , and the expression of IgG is involved in the cancer progression. If IgG expression can serve as a potential target in cancer therapies and be used for judging the prognosis. MATERIALS AND

methodsBy immunohistochemistry, we detected IgG in cRCC tissues(75 cRCC tissues and75 adjacent normal kidney tissues). Immunofluorescence and Western blot was used to detect the IgG in cRCC cell lines (786-0, ACHN and CAKI-I). By RT-PCR, the functional transcript of IgG heavy chain was detected. Knockdown of IgG was to analyze the proliferation, migration and invasion ability by CCK8, Transwell and Matrigel and apoptosis in cRCC cell lines.

resultsBy immunohistochemistry, we found strong staining of IgG in 66 cases of 75 cRCC tissues and 63 cases of 75 adjacent normal kidney tissues. Immunofluorescence and Western blot was found IgG in cRCC cell lines. Knock-down IgG in cRCC cell lines resulted in significant inhibition of cell proliferation, migration and invasion, and the induction of apoptosis of the 786-0 cells. The immunohistochemistry analysis showed that high IgG expression significantly correlated with the poor differentiation and advanced stage of cRCC.

conclusionIgG was over expressed in cRCC and was involved in the proliferation, migration and invasion of cancer cells. IgG expression may serve as a potential target in cancer therapies and could be used for judging the prognosis.

Indexed as

Gene Expression Regulation, NeoplasticApoptosisBiomarkers, TumorCarcinoma, Renal CellCell Line, TumorCell MovementCell ProliferationDisease ProgressionFemaleHumansImmunoglobulin GImmunohistochemistryKidneyKidney NeoplasmsMaleMiddle AgedBiomarkers, TumorImmunoglobulin GRENAL CANCERTUMOUR BIOLOGYTUMOUR MARKERS

Identifiers

PMID26519488
PMCPMC4893138
OpenAlexW1881292126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.